Latest Breaking News On - European hematology association - Page 7 : comparemela.com

Innate Pharma SA: Innate Pharma: Clarification Regarding SAR443579 Designation

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association

France
French
Henry-wheeler
Arthur-rouill
Company-annual-report-on-form
Nasdaq
Euronext
French-financial-markets-authority
Exchange-commission
Linkedin
Astrazeneca
European-hematology-association

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Spain
Ying-qian
Jiangxi
China
Madrid
Tianjin
Texas
United-states
Shanghai
Wuhan
Hubei
Norway

WU-CART-007 Receives FDA RMAT and EMA PRIME Designations for R/R T-ALL and T-LBL

WU-CART-007 has received RMAT and PRIME designations in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Jan-davidson-moncada
European-hematology-association
World-health-organization
European-medicines-agency

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.

Beijing
China
Spain
Tianjin
Shanghai
Oslo
Norway
Wuhan
Hubei
Ying-qian
Jiangxi
Valencia

HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress

Spain
Cheng-mei
Guangdong
China
Oslo
Norway
Hong-kong
Tianjin
Houston
Texas
United-states
Beijing

Latest Breaking News On - European hematology association - Page 7 : comparemela.com

Innate Pharma SA: Innate Pharma: Clarification Regarding SAR443579 Designation

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

WU-CART-007 Receives FDA RMAT and EMA PRIME Designations for R/R T-ALL and T-LBL

WU-CART-007 has received RMAT and PRIME designations in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma. Jan-davidson-moncadaEuropean-hematology-associationWorld-health-organizationEuropean-medicines-agency

HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.BeijingChinaSpainTianjinShanghaiOsloNorwayWuhanHubeiYing-qianJiangxiValencia

HUTCHMED Data to be Presented at EHA2024 Congress | Company Announcement

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 CongressSpainCheng-meiGuangdongChinaOsloNorwayHong-kongTianjinHoustonTexasUnited-statesBeijing

WU-CART-007 has received RMAT and PRIME designations in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

Jan-davidson-moncada
European-hematology-association
World-health-organization
European-medicines-agency

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 HUTCHMED Limited today announces that topline and subgroup results from the ESLIM-01 Phase III study of sovleplenib, as well as new.

Beijing
China
Spain
Tianjin
Shanghai
Oslo
Norway
Wuhan
Hubei
Ying-qian
Jiangxi
Valencia

Investegate announcements from HUTCHMED Data to be Presented at EHA2024 Congress

Spain
Cheng-mei
Guangdong
China
Oslo
Norway
Hong-kong
Tianjin
Houston
Texas
United-states
Beijing